KOSPIChemicals007590

Dongbang Agro

₩5,400▼ 1.46%2026-11-18 close
Market Cap
₩73.5B
Turnover
₩2,357,200
Volume
434 shares
Shares out.
13.6M
PER
7.3×
PBR
0.4×
EPS
₩732
Dividend Yield
5.95%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩320 per share · Prices as of the 2026-11-18 close

01

Report overview

Quarterly swings widen at pesticide maker, back in loss in Q3 2026

Dongbang Agro's revenue grew for three straight years through 2025, but its 2026 quarterly results have swung sharply, from an operating profit in Q1 to an operating loss in Q3.

  1. 1

    Revenue rose 5.1% to KRW 179 billion in 2025, while operating profit fell 13.4% to KRW 12.7 billion.

  2. 2

    Q1 2026 was the quarterly peak, with revenue of KRW 104.4 billion and operating profit of KRW 17.2 billion; revenue then fell to KRW 48.9 billion in Q2 and KRW 19.8 billion in Q3.

  3. 3

    Q3 2026 returned to the red, with an operating loss of KRW 4.95 billion and a net loss attributable to controlling shareholders of KRW 3.59 billion.

  4. 4

    A February 2026 pesticide supply contract with a domestic agricultural cooperative's economic holding company is worth KRW 85.9 billion including VAT, equal to 50.48% of recent revenue, and runs through December 31, 2026.

  5. 5

    The corporate value-up plan disclosed in March 2026 sets a dividend payout target of at least 40% of net income attributable to controlling shareholders.

02

Business structure

Dongbang Agro was founded in 1971 as a manufacturer and seller of agricultural chemicals and listed on the KOSPI in 1977. Its main product line is emulsifiable concentrates, followed by granules, wettable powders and dusts.

By segment, 2026 Q2 sales were 60% emulsifiable concentrates, 23% granules, 15% wettable powders, 1% other and 1% dusts. The company has a subsidiary, Dongbang Green Farm.

It continues to invest in automated production lines to make mixed formulations and is broadening its product mix with multifunctional eco-friendly fertilizers.

Active ingredients are sourced through a strategic partnership with leading global technical-grade manufacturers, which underpins its product development and supply to farms. The company says it will pursue new substances by drawing on its product development capability and marketing strategy.

Its labor-saving formulation development targets products that reduce farmers' workload, and the company credits it with supporting sales. On the customer side, a February 2026 pesticide supply contract with a domestic agricultural cooperative's economic holding company is disclosed, equal to 50.48% of recent revenue.

According to a foreign financial information site, Sumitomo Corporation (14.32%) and Sumitomo Chemical (5.79%) were listed as holders as of March 31, 2026.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩18.9B-₩5.6B−29.5%
2025Q4₩15.1B-₩2.4B−15.9%
2026Q1₩104.4B₩17.2B16.4%
2026Q2₩48.9B₩2.1B4.4%
2026Q3₩19.8B-₩5B−25.0%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩146.7B₩9.3B₩6.8B6.4%4.5%43.6%
2023₩164.3B₩13.6B₩12.1B8.3%7.6%40.3%
2024₩170.2B₩14.6B₩9.8B8.6%5.9%43.7%
2025₩179B₩12.7B₩9.7B7.1%5.6%43.8%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

Annual revenue rose from KRW 146.7 billion in 2022 to KRW 164.3 billion in 2023 (up 12.0% year on year), KRW 170.2 billion in 2024 (up 3.6%) and KRW 179 billion in 2025 (up 5.1%), growing for three consecutive years from 2023 through 2025.

Operating profit climbed from KRW 9.34 billion in 2022 to KRW 13.6 billion in 2023 (up 45.5%) and KRW 14.6 billion in 2024 (up 7.5%), then fell to KRW 12.7 billion in 2025 (down 13.4%). The operating margin was 6.4% in 2022, 8.3% in 2023, 8.6% in 2024 and 7.1% in 2025, easing after the 2024 peak.

Net income attributable to controlling shareholders rose from KRW 6.78 billion in 2022 to KRW 12.1 billion in 2023 (up 79.0%), then declined to KRW 9.76 billion in 2024 (down 19.5%) and KRW 9.75 billion in 2025 (down 0.1%), a two-year decline.

Net income including non-controlling interests was KRW 6.79 billion, KRW 12.2 billion, KRW 9.79 billion and KRW 9.77 billion in the same years, so the gap with controlling-shareholder income is about KRW 0.1 billion to KRW 1 billion.

Operating cash flow was KRW 8.73 billion in 2025, up from KRW 327 million in 2024, and was negative in 2023. The debt ratio stayed in the low-40% range, at 43.6% in 2022, 40.3% in 2023, 43.7% in 2024 and 43.8% in 2025.

On a quarterly basis, Q3 2025 revenue was KRW 18.9 billion with an operating loss of KRW 5.59 billion and a net loss attributable to controlling shareholders of KRW 3.71 billion. Q4 2025 revenue was KRW 15.1 billion, with an operating loss of KRW 2.4 billion, so the loss narrowed but persisted.

Q1 2026 revenue jumped to KRW 104.4 billion (up 589.9% from the prior quarter) and operating profit reached KRW 17.2 billion, a swing to profit, with net income attributable to controlling shareholders at KRW 12.7 billion. The disclosed table alone does not pin down the cause of the Q1 revenue surge.

Q2 2026 revenue fell to KRW 48.9 billion (down 53.2% quarter on quarter), operating profit to KRW 2.14 billion (down 87.6%) and net income attributable to controlling shareholders to KRW 1.81 billion.

Q3 2026 revenue was KRW 19.8 billion (up 4.5% year on year), but the company posted an operating loss of KRW 4.95 billion and a net loss attributable to controlling shareholders of KRW 3.59 billion. The operating loss was smaller than a year earlier.

Net income attributable to controlling shareholders over the latest four quarters (Q4 2025 to Q3 2026) totaled KRW 9.26 billion.

05

Industry analysis

Pesticide demand is being shaped by dietary change and climate change. Westernized eating habits and climate change are cited as reasons pesticide consumption is declining. In response, the company says it is adapting marketing and labor-saving formulations to changing crop cultivation conditions.

One external aggregator reports Q1 2026 revenue up 0.3%. Compared with the chemical sector as a whole, Dongbang Agro's 2025 annual operating margin of 7.07% sits well above the sector average of 1.00%, based on 121 chemical-sector stocks in an Alphasquare aggregation.

In the same aggregation, its market capitalization ranks 81st within the sector, in the lower-middle range. Active ingredients are sourced through partnerships with leading global technical-grade manufacturers, so the supply side relies on those alliances.

In domestic sales, the contract with the agricultural cooperative's economic holding company equals 50.48% of recent revenue, which makes dependence on a single customer a point to watch.

Direct comparison of industry-wide supply and demand indicators with disclosed data is limited, so the position is best read through company disclosures and sector-level aggregates.

06

Outlook

In its 2026 corporate value-up plan, the company said it will continue to pursue new substances and to invest in optimizing production facilities. On dividends, it set a payout target of at least 40% of net income attributable to controlling shareholders.

The payout ratio for fiscal 2025, the most recent completed year, was 41.41%. The company states that dividend levels are set after considering the business environment, investment plans and financial structure. The results of the regular shareholders' meeting held on March 20, 2026 are on record.

The February 2026 supply contract runs domestically from February 5 to December 31, 2026, and volumes and amounts may change at the request of the buyer. The contract carries no advance payment.

In August 2025, the company decided to dispose of 1 million treasury shares, worth KRW 690 million per the disclosure's share price basis, to support an exchangeable bond issuance, which it described as a step to improve financial structure and secure liquidity.

Q4 2026 results have not yet appeared in a periodic report, so the next checkpoint is the annual figures in the 2026 business report.

07

Valuation

PER
7.3×
PBR
0.4×
ROE
5.2%
EPS
₩732
BPS
₩14,310
Dividend per share
₩320

Dongbang Agro trades below its book value per share, so the stock carries no premium over net asset value. Its price-to-book ratio sits below 1x, placing the market price relatively low against asset value. The dividend yield is above the chemical-sector average, a high level within the sector on a dividend basis.

On earnings, controlling-shareholder net income declined in both 2024 and 2025, and operating profit fell in 2025, so the decline in earnings shapes how multiples are read.

Net income attributable to controlling shareholders over the latest four quarters totals KRW 9.26 billion, which is not far from the 2025 annual figure. Operating losses appeared in Q3 2025, Q4 2025 and Q3 2026, so the earnings base shifts from quarter to quarter.

Because the payout target ties dividends to at least 40% of controlling-shareholder net income, dividend levels move with earnings.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Shareholder return target

In a March 2026 disclosure, the company set a dividend payout target of at least 40% of net income attributable to controlling shareholders. The payout ratio for 2025, the latest completed year, was 41.41%. Because the dividend base is linked to net income, it should be read alongside the 2026 earnings trend. Whether the stated target is met will be shown in periodic reports.

Q1 turnaround and a large contract

Q1 2026 operating profit swung to KRW 17.2 billion on revenue of KRW 104.4 billion. The supply contract signed with the agricultural cooperative's economic holding company in February 2026 is worth KRW 85.9 billion including VAT, equal to 50.48% of recent revenue. The contract runs through December 31, 2026. Whether it drove the quarterly swing will be checked against future periodic reports.

Balance sheet stability

At the end of 2025, total liabilities were KRW 76.3 billion and total equity KRW 174.2 billion, with a debt ratio of 43.8%. The debt ratio fell from 43.6% in 2022 to 40.3% in 2023 and has since stayed in the 40% range. A modest liability load relative to equity leaves room during periods of earnings volatility. Equity attributable to controlling shareholders was KRW 173.6 billion, most of total equity.

09

Bear factors

Sharp quarterly volatility

Q2 2026 revenue fell to KRW 48.9 billion, down 53.2% from the prior quarter, and operating profit dropped to KRW 2.14 billion, down 87.6%. Q3 2026 revenue was KRW 19.8 billion, and the company returned to an operating loss of KRW 4.95 billion. The Q3 operating loss was narrower than a year earlier. The thinner quarterly earnings base after the Q1 peak is the starting point of the bear case.

Slowing earnings momentum

Operating profit fell 13.4% from KRW 14.6 billion in 2024 to KRW 12.7 billion in 2025, and net income attributable to controlling shareholders declined in both 2024 and 2025. The operating margin eased from 8.6% in 2024 to 7.1% in 2025.

Controlling-shareholder net income over the latest four quarters totals KRW 9.26 billion. Whether the post-peak decline in annual earnings continues is the central question for the bear case.

Structural change in pesticide use

Westernized diets and climate change are cited as factors reducing pesticide consumption. The company says it is responding through labor-saving formulations and marketing. Whether these efforts have offset weaker demand cannot be judged from disclosures alone.

In a period of shifting demand structure, the pace of revenue recovery could be limited, which is the core bearish point.

10

Risk factors

Contract renewal

The supply contract with the agricultural cooperative's economic holding company ends on December 31, 2026, and volumes and amounts may change at the buyer's request. The contract carries no advance payment.

Because it equals 50.48% of recent revenue, the terms of any follow-on contract will bear directly on the revenue trend.

Treasury shares and exchangeable bond

In August 2025, the company disclosed plans to dispose of 1 million treasury shares, worth KRW 690 million, to support an exchangeable bond issuance. The company described the step as a measure to improve its financial structure and secure liquidity. Because the exchange structure is linked, changes in share count should be followed through later disclosures.

Major shareholder stake changes

A disclosure dated April 15, 2026 lists a change of about 1.06 million shares, recorded as a decrease, for reporter Yeom Byeong-man. The effect of this stake change on market supply and demand cannot be determined from the filing alone. The shareholder structure will be confirmed again in periodic reports.

11

What to watch next

  1. December 31, 2026

    The supply contract with the agricultural cooperative's economic holding company ends. Whether a follow-on contract is signed, and on what terms, bears on the revenue mix from 2027.

  2. Early 2027

    Preliminary Q4 2026 results are expected around this time. Because Q4 has not yet appeared in a periodic report, preliminary figures should be distinguished from the final figures in the business report.

  3. By end-March 2027

    The deadline for the 2026 business report is typically the end of March. The report will show the annual operating margin, operating cash flow, debt ratio and whether the 40% or higher payout target was met.

12

Overall view

Dongbang Agro is a pesticide maker centered on emulsifiable concentrates. Revenue grew for three consecutive years through 2025, but operating profit and net income attributable to controlling shareholders have declined since 2024.

Q1 2026 brought both revenue and a profit, but revenue and earnings fell sharply after that, and Q3 returned to an operating loss. Bullish factors include the payout target of at least 40%, a debt ratio that has stayed in the 40% range, and a share price below book value per share.

Bearish factors include large quarterly swings, a decline in annual earnings, structural change in pesticide demand, and uncertainty after the cooperative contract ends. The weight of both sides is similar, so neither can be declared dominant.

The next checkpoints are the December 31, 2026 contract end, preliminary Q4 2026 results in early 2027, and the annual figures and dividend decision in the 2026 business report. This report is for information only and does not include a buy or sell opinion.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 16 more articles and sources
  1. comp.fnguide.com
  2. news.nate.com
  3. alphasquare.co.kr
  4. butler.works
  5. kpinfo.kr
  6. news.nate.com
  7. news.nate.com
  8. accidentalorder.com
  9. digitaltoday.co.kr
  10. comp.fnguide.com
  11. pflow.keywordegg.com
  12. comp.wisereport.co.kr
  13. judal.co.kr
  14. judal.co.kr
  15. judal.co.kr
  16. investing.com

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis